ASSOCIATION BETWEEN ADMISSION PROTHROMBIN TIME AND 30-DAY CARDIOVASCULAR EVENTS IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS INTERVENTION

Tùng Ngô Quang, Quân Nguyễn Mạnh, Quân Nguyễn Mạnh

Main Article Content

Abstract

Background: Acute coronary syndrome (ACS) is a critical manifestation of coronary artery disease involving endothelial dysfunction, inflammation, and thrombosis. Prothrombin time (PT), reflecting the extrinsic coagulation pathway, may be linked to adverse outcomes in acute cardiovascular conditions.


Objective: To investigate the association between admission PT and 30-day cardiovascular events in ACS patients undergoing percutaneous coronary intervention. Methods: A prospective observational study was conducted on 188 ACS patients treated with PCI. Patients were categorized into Group I (PT < 14 seconds) and Group II (PT ≥ 14 seconds) based on admission PT. Results: The 30-day mortality rate was significantly higher in Group II (15.2%) compared to Group I (3.3%) (p = 0.017). No significant differences were observed between groups in terms of rehospitalization, stroke, recurrent myocardial infarction, or bleeding. The MACE rate was higher in Group II (21.2% vs. 15.7%, p = 0.3). Univariate Cox regression showed each 1-second increase in PT was associated with a 1.68-fold increase in mortality (p < 0.01); multivariate analysis confirmed a 1.54-fold increase (95% CI: 1.1–2.1, p < 0.01). PT significantly improved the predictive power of a mortality model, raising the AUC from 0.712 to 0.726 (p = 0.0118). Conclusion: Prolonged admission PT is an independent predictor of 30-day mortality in ACS patients undergoing PCI and improves the performance of multivariable prognostic models.

Article Details

References

1. Abbate, R., Cioni, G., Ricci, I., Miranda, M., & Gori, A. M. (2012). Thrombosis and acute coronary syndrome. Thrombosis Research, 129(3), 235–240. https://doi.org/10.1016/ j.thromres.2011.12.026
2. Khan, H. A., Alhomida, A. S., Rammah, T. Y. A., Sobki, S. H., Ola, M. S., & Khan, A. A. (2013). Alterations in prothrombin time and activated partial thromboplastin time in patients with acute myocardial infarction. International Journal of Clinical and Experimental Medicine, 6(4), 294–297. https://www.ncbi.nlm.nih.gov/ pmc/articles/PMC3631555/
3. Kırış, T., Yazıcı, S., Durmuş, G., et al. (2018). The relation between international normalized ratio and mortality in acute pulmonary embolism: A retrospective study. Journal of Clinical Laboratory Analysis, 32(1), e22164. https://doi.org/10.1002/jcla.22164
4. Mozaffarian, D., Benjamin, E. J., Go, A. S., et al. (2015). Heart disease and stroke statistics—2015 update: A report from the American Heart Association. Circulation, 131(4), e29–e322. https://doi.org/10.1161/CIR.0000000000000152
5. Okada, A., Sugano, Y., Nagai, T., et al. (2016). Prognostic value of prothrombin time international normalized ratio in acute decompensated heart failure: A combined marker of hepatic insufficiency and hemostatic abnormality. Circulation Journal: Official Journal of the Japanese Circulation Society, 80(4), 913–923. https://doi.org/10.1253/circj.CJ-15-1326
6. Sadrnia, S., Pourmoghaddas, M., Hadizadeh, M., et al. (2013). Factors affecting outcome of primary percutaneous coronary intervention for acute myocardial infarction. ARYA Atherosclerosis, 9(4), 241–246. https://www.ncbi.nlm.nih.gov/ pmc/articles/PMC3746947/
7. Undas, A., Ziedins, K., & Mann, K. (2009). Mechanisms of thrombosis in ACS: The role of the plasma coagulation pathway. Acute Coronary Syndromes, 9, 134–140.
8. Prognostic value of prothrombin time in patients with acute coronary syndrome undergoing percutaneous coronary intervention. ResearchGate. https://doi.org/ 10.5578/khj.66119